Perseus Proteomics

Japan
Tokyo, Tokyo, Japan
+81 3-5738-1705 ★

Company profile

Perseus Proteomics company profile

PePerseus Proteomics is a drug discovery biotechnology venture that uses advanced antibody technology to pursue superior antibody production technology and create new medicines powerfully for people around the world who are waiting for better medical care .

Business identity

Contact email
[email protected]
Phone number
+81 3-5738-1705
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$0+
Founded
2001-02-01

Headquarters

Headquarters
Tokyo, Tokyo, Japan
Postal code
103-0015
Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
7
Total equity funding
$51.9M
Last funding
Series Unknown / $1.3M / 2020-11-30
Last equity funding
Series Unknown / $1.3M
Investors
13
Lead investors
3
Founders
1
Articles
6
Exited on
2009-02-03

Founders and investors

Founders

Takuya Yokokawa

Lead investors

CMICMitsubishi UFJ CapitalNewton Biocapital

Investors

Kyoto University Innovation CapitalMitsubishi UFJ CapitalMizuho CapitalSBI InvestmentSMBC Venture Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.